Ann: USA FDA Grants Orphan Drug Status for PAT-SM, page-50

re: Ann: USA FDA Grants Orphan Drug Status fo... Oscarone - you're certainly right about it being "a changing of the guard". Over 60 million shares traded today. A lot of long-term holders have dumped and got out and the day-traders have had a field day but now we have a lot more new investors, some of whom will be looking at the stock closely with a view to increasing their tranche.

I expect more volatility over the next week but expect the price will rise and keep on until at least 5. After that, we're waiting on the results.

May I remind everyone that PAB is presenting it's data at ASH
between the 7th-10th December? That being so, I think they're legally bound to release the data from the 4th cohort to the ASX before that. So we shouldn't have long to wait. And, God willing, I expect that data to be as least as good as the previous trials.

Onward and upwards